Gene expression in obliterative bronchiolitis-like lesions in 2,3-pentanedione-exposed rats

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Morgan, Daniel L ^a   Merrick, B Alex ^a   Gerrish, Kevin E ^a   Stockton, Patricia S ^a   Wang, Yu ^a   Foley, Julie F ^a   Gwinn, William M ^a   Kelly, Francine L ^b   Palmer, Scott M ^b   Ton, Thai Vu T ^a   Flake, Gordon P ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 PENTANEDIONE; ACETYLACETONE; CHEMOKINE; COLLAGEN; CYTOKINE; FIBRONECTIN; INTERLEUKIN 1ALPHA; PEPTIDASE; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; 2,3-PENTANEDIONE; ALKANONE; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS OBLITERANS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HISTOPATHOLOGY; LUNG FIBROSIS; MALE; MICROARRAY ANALYSIS; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; BRONCHUS; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; EXPOSURE; FIBROSIS; GENETICS; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WISTAR RAT;

ANIMALIA; RATTUS;

ANIMALS; BRONCHI; BRONCHIOLITIS OBLITERANS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FIBROSIS; IMMUNOHISTOCHEMISTRY; INHALATION EXPOSURE; MALE; PENTANONES; PRINCIPAL COMPONENT ANALYSIS; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RNA; TRANSFORMING GROWTH FACTOR BETA2; UP-REGULATION;

EID: 84923350482     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118459     Document Type: Article

References (64)

1. Ryu JH, Myers J, Swenson SJ. Bronchiolar disorders. Am J Resp Crit Care Med. 2003; 168(11):1277-92. PMID: 14644923
2. Kreiss K, Gomaa A, Kullman G, Fedan K, Simoes EJ, Enright PL. Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. N Engl J Med. 2002; 347(5):330-8. PMID: 12151470.
3. Morgan DL, Jokinen MP, Johnson CL, Gwinn WM, Price HC, Flake GP. Bronchial fibrosis in rats exposed to 2,3-butanedione and 2,3-pentanedione. Toxicologist. 2012; 126(1):866.
4. Weng L, Dai H, Zhan Y, He Y, Stepaniants S, Bassett DE. Rosetta error model for gene expression analysis. Bioinformatics. 2006; 22(9):1111-21. PMID: 16522673
5. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Research. 2002; 30(1):207-10. PMID: 11752295
6. Bergmann M, Tiroke A, Schafer H, Barth J, Haverich A. Gene expression of profibrotic mediators in bronchiolitis obliterans syndrome after lung transplantation. Scand Cardiovasc J. 1998; 32:97-103. PMID: 9636965
7. Elssner A, Jauman F, Dobmann S, Behjr J, Schwaiblmair M, Reichenspurner H, et al. Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: Proinflammatory role of bronchial epithelial cells. Transplantation. 2000; 70(2):362-7. PMID: 10933164
8. Zheng L, Walters EH, Wang N, Whitford H, Orsida B, Levvey B, et al. Effect of inhaled fluticasone propionate on BAL TGF-β1 and bFGF concentrations in clinically stable lung transplant recipients. The Journal of Heart and Lung Transplantation. 2004; 23(4):446-55. doi: 10.1016/s1053-2498(03)00199-2 PMID: 15063404
9. El-Gamel A, Sim E, Hasleton P, Hutchinson J, Yonan N, Egan J, et al. Transforming growth factor beta (TGF-b) and obliterative bronchiolitis following pulmonary transplantation. J Heart lung Transplant. 1999; 18:828-37. PMID: 10528744
10. Ask K, Bonniaud P, Maass K, Eickelberg O, Margetts PJ, Warburton D, et al. Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but not TGF-beta3. The international journal of biochemistry & cell biology. 2008; 40(3):484-95. doi: 10.1016/j.biocel.2007.08.016 PMID: 17931953; PubMed Central PMCID: PMC2350199.
11. Thompson HGR, Mih JD, Krasieva TB, Tromberg BJ, George SC. Epithelial-derived TGFB2 modulates basal and wound-healing subepithelial matrix homeostasis. Am J Physiol Lung Cell Mol Physiol. 2006; 291:L1277-L85. PMID: 16891397
12. Balzar S, Chu HW, Silkoff P, Cundall M, Trudeau JB, Strand M, et al. Increased TGF-beta2 in severe asthma with eosinophilia. The Journal of allergy and clinical immunology. 2005; 115(1):110-7. doi: 10. 1016/j.jaci.2004.09.034 PMID: 15637555.
13. Tschumperlin DJ. Mechanical stress triggers selective release of fibrotic mediators from bronchial epithelium. American journal of respiratory cell and molecular biology. 2003; 28(2):142-9. doi: 10.1165/rcmb.2002-0121OC PMID: 12540481
14. Puddicombe SM, Polosa R, Richter A, Krishna MT, Howarth PH, Holgate ST, et al. Involvement of the epidermal growth factor receptor in epithelial repair in asthma. Faseb Journal. 2000; 14(10):1362-74. doi: 10.1096/fj.14.10.1362 PubMed PMID: WOS:000087932200011. PMID: 10877829
15. Schmidt JA, Mizel SB, Cohen D, Green I. Interleukin-1, a potential regulator of fibroblast proliferation. J Immunol. 1982; 128(5):2177-82. PMID: 6460819
16. Postlewaite AE, Lachman LB, Kang AH. Induction of fibroblast prolilferation by interleukin-1 derived from human monocytic leukemia cells. Arthritis Rheum 1984; 27(9):995-1001. PMID: 6332633
17. Matsushima K, Bano M, Kidwell W, Oppenheim JJ. Interleukin 1 increases collagen type IV production by murine mammary epithelial cells. J Immunol. 1985; 134(2):904-9. PMID: 3871221
18. Havemose-Poulsen A, Holstrup P. Factors affecting IL-1-mediated collagen metabolism by fibroblasts and the pathogenesis of periodontal disease: A review of the literature. Crit Rev Oral Miol Med. 1997; 8 (2):217-36. PMID: 9167094
19. Aoki J, Inoue A, Okudaira S. Two pathways for lysophosphatidic acid production. Biochimica et biophysica acta. 2008; 1781(9):513-8. doi: 10.1016/j.bbalip.2008.06.005 PMID: 18621144.
20. Kawayama T, Okamoto M, Imaoka H, Kato S, Young HA, Hoshino T. Interleukin-18 in pulmonary inflammatory diseases. Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research. 2012; 32(10):443-9. doi: 10.1089/jir.2012.0029 PMID: 22900713.
21. Lloyd CM. IL-33 family members and asthma - bridging innate and adaptive immune responses. Current opinion in immunology. 2010; 22(6):800-6. doi: 10.1016/j.coi.2010.10.006 PMID: 21071194; PubMed Central PMCID: PMC3380518.
22. Fix C, Bingham K, Carver W. Effects of interleukin-18 on cardiac fibroblast function and gene expression. Cytokine. 2011; 53(1):19-28. doi: 10.1016/j.cyto.2010.10.002 PubMed PMID: WOS:000286862700006. PMID: 21050772
23. Hoshino T, Okamoto M, Sakazaki Y, Kato S, Young HA, Aizawa H. Role of proinflammatory cytokines IL-18 and IL-1beta in bleomycin-induced lung injury in humans and mice. American journal of respiratory cell and molecular biology. 2009; 41(6):661-70. doi: 10.1165/rcmb.2008-0182OC PMID: 19265174.
24. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005; 23(5):479-90. doi: 10.1016/j.immuni.2005.09.015 PMID: 16286016.
25. Cayrol C, Girard JP. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106(22):9021-6. doi: 10.1073/pnas.0812690106 PMID: 19439663; PubMed Central PMCID: PMC2690027.
26. Brunner SM, Schiechl G, Falk W, Schlitt HJ, Geissler EK, Fichtner-Feigl S. Interleukin-33 prolongs allograft survival during chronic cardiac rejection. Transplant international: official journal of the European Society for Organ Transplantation. 2011; 24(10):1027-39. doi: 10.1111/j.1432-2277.2011.01306.x PMID: 21797940.
27. Varga J, Rosenbloom J, Jiminez SA. Transforming growth factor-beta (TGFB) causes a persistent increase in steay-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J. 1987; 247:597-604. PMID: 3501287
28. Roberts CJ, Birkenmeier TM, McQuillan JJ, Akiyama SK, Yamada SS, Chen W, et al. Transforming growth factor B stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human llung fibroblasts. J Biol Chem. 1988; 263(10):4586-92. PMID: 2965146
29. Bitterman PB, Rennard SI, Adelberg S, Crystal RG. Role of fibronectin as a growth factor for fibroblasts. J Cell Biol. 1983; 97(6):1925-32. PMID: 6358238
30. Limper AH, Roman J. Fibronectin, a versatile matrix protein with roles in thoracic development, repair and infection. Chest. 1992; 101:1663-73. PMID: 1534744
31. Streichenberger N, Peyrol S, Philit F, Loire R, Sommer P, Cordier JF. Constrictive bronchiolitis obliterans-characterization of fibrogenesis and lysyl oxidase expression patterns. Vir Arch Int J Pathol. 2001; 439(1):78-84.
32. Beeh KM, Meier J, Kornmann O, Micke P, Buhl R. Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and their ratio correlate with airway obstruction in lung transplant recipients: Relation to tumor necrosis factor-alpha and interleukin-10. J Heart Lung Transplant. 2001; 20 (11):1144-51. PMID: 11704473
33. Hubner RH, Meffert S, Mundt U, Bottcher H, Freitag S, El Mokhtari NE, et al. Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 2005; 25(3):494-501. doi: 10.1183/09031936.05.00091804 PMID: 15738294.
34. Fernandez FG, Campbell LG, Liu W, Shipley JM, Itohara S, Patterson GA, et al. Inhibition of obliterative airway disease development in murine tracheal allografts by matrix metalloproteinase-9 deficiency. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2005; 5(4 Pt 1):671-83. doi: 10.1111/j.1600-6143.2005.00751.x PMID: 15760390.
35. Sato M, Keshavjee S, Liu M. Translational research: animal models of obliterative bronchiolitis after lung transplantation. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2009; 9(9):1981-7. doi: 10.1111/j.1600-6143.2009.02770.x PMID: 19663891.
36. Biernacka A, Dobaczewski M, Frangogiannis NG. TGF-beta signaling in fibrosis. Growth factors. 2011; 29(5):196-202. doi: 10.3109/08977194.2011.595714 PMID: 21740331.
37. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGF beta activation. J Cell Sci. 2003; 116 (2):217-24.
38. Solberg H, Ploug M, Hoyer-Hansen G, Nielsen BS, Lund LR. The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling. Journal of Histochemistry & Cytochemistry. 2001; 49(2):237-46. doi: 10.1177/002215540104900211
39. Askew DJ, Silverman GA. Intracellular and extracellular serpins modulate lung disease. Journal of perinatology: official journal of the California Perinatal Association. 2008; 28 Suppl 3:S127-35. doi: 10.1038/jp.2008.150 PMID: 19057604.
40. Mehuron T, Kumar A, Durarte L, Yamauchi J, Accorsi A, Girgenrath M. Dysregulation of matricellular proteins is an early signature of a pathology in laminin-deficient muscular dystrophy. Skeletal Muscle. 2014; 4:4-14. doi: 10.1186/2044-5040-4-4 PMID: 24484587
41. O'Regan A. The role of osteopontin in lung disease. Cytokine & Growth Factor Reviews. 2003; 14 (6):479-88.
42. Zhao Y, Young SL, McIntosh JC. Induction of tenascin in rat lungs undergoing bleomycin-induced pulmonary fibrosis. AmJ PhysiolLung Cell Molec Physiol. 1998; 274(6):L1049-L57. PMID: 9609745
43. Kaminski N, Allard JD, Pittet JF, Zuo FG, Griffiths MJD, Morris D, et al. Global anaysis of gene expression in pulmonary fibrosis reveal distinct programs regulating lung inflammation and fibrosis. PNAS USA. 2000; 97(4):1778-83. PMID: 10677534
44. Zuo FR, Kaminski N, Eugui E, Allard JD, Yakhini Z, Ben-Zor A, et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. PNAS USA. 2002; 99(9):6292-7. PMID: 11983918
45. Lofdahl M, Kaarteenaho R, Lappi-Blanco E, Tornling G, Skold MC. Tenascin-C and alpha-smooth muscle actin positive cells are increased in the large airways in patients with COPD. Respiratory research. 2011; 12:48. doi: 10.1186/1465-9921-12-48 PMID: 21496259; PubMed Central PMCID: PMC3083344.
46. Laitinen LA, Altraja A, Kampe M, Linden M, Virtanen I, Laitenin LA. Tenascin is increased in airway basement membane of asthmatics and decreased by an inhaled steroid Am J Resp Crit Care Med. 1997; 156(3):951-8. PMID: 9310019
47. Hibino S, Kato K, Kudoh S, Yagita H, Okumura K. Tenascin suppresses CD-3-mediated T cell activation. Biochem Biophys Res Com. 1998; 250(1):119-1254. PMID: 9735343
48. Paivaniemi OE, Maasilta PK, Alho HS, Vainikka TLS, Sahninen US. Epithelial tenascin predicts obliterative airwaiy disease J Heart Lung Transplant. 2008; 27(4):400-7. doi: 10.1016/j.healun.2008.01.009 PMID: 18374876
49. Carey WA, Taylor GD, Dean WB, Bristow JD. Tenascin-C deficiency attenuates TGF-B-mediated fibrosis following murine lung injury. AmJ Physiol Lung Cell Molec Physiol. 2010; 299:L785-L93.
50. Palmer SM, Flake GP, Kelly FL, Zhang HL, Nugent JL, Kirby PJ, et al. Severe airway epithelial injury, aberrant repair and bronchiolitis obliterans develops after diacetyl instillation in rats. PloS one. 2011; 6 (3). doi: 10.1371/journal.pone.0017644 PubMed PMID: WOS:000288813900004.
51. Oshika Y, Masudaa K, Tokanaga T, Hatanaka H, Kamiya T, Abe Y, et al. Thrombospondin 2 gene expression is correlated with decreased vascularity in non-small cell lung cancer. Clin Cancer Res. 1998; 4(7):1785-8. PMID: 9676856
52. Tokunaga T, Nakamura M, Oshika Y, Abe Y, Ozeki Y, Fukushima Y, et al. Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer. Brit J Cancer. 1999; 79(2):354-9. PMID: 9888480
53. Bornstein P, Armstrong LC, Hankenson KD, Kyriakides TR, Yang Z. Thrombospondin 2, a matricellular protein with diverse functions. Matrix Biol. 2000; 19(7):557-67. PMID: 11102746
54. Adams JC, Lawler J. The Thrombospondins. Cold Spring Harb Perspect Biol. 2011; 3:a009712. doi:10.1101 PMID: 21875984
55. Chijiwa T, Abe Y, Ikoma N, Yamazaki H, Tsukamoto H, Suemizu H, et al. Thrombospondin 2 inhibits metastasis of human malignant melanoma through microenvironment-modification in NOD/SCID/γc null (NOG) mice. Int J Oncol. 2009; 34:5-13. PMID: 19082472
56. Kamochi J, Tokanaga T, Tomii Y, Abe Y, Hatanaka H, Kijima H, et al. Overexpression of the thrombospondin 2 gene modulated by the matrix metalloproteinase family expression and production in human colon carcinoma cell line. Oncol Reports. 2003; 10(4):881-4. PMID: 12792739
57. Koval M. Claudin heterogeneity and control of lung tight junctions. Ann Rev Physiol. 2013; 75:551-67. doi: 10.1146/annurev-physiol-030212-183809 PMID: 23072447
58. Jin W, Rong L, Liu Y, Song Y, Li Y, Pan J. Increased claudin-3, -4 and -18 levels in bronchoalveolar lavage fluid reflect severity of acute lung injury. Respirology. 2013; 18:643-51. doi: 10.1111/resp.12034 PMID: 23253121
59. Ohta H, Chiba S, Ebina M, Furuse M, Nukiwa T. Altered expression of tight junction molecules in alveolar septa in lung injury and fibrosis. American journal of physiology Lung cellular and molecular physiology. 2012; 302(2):L193-205. Epub 2011/10/18. doi: 10.1152/ajplung.00349.2010 PMID: 22003091.
60. Jiang L, Liu CY, Yang QF, Wang P, Zhang W. Plasma level of growth arrest-specific 6 (GAS6) protein and genetic variations in the GAS6 gene in patients with acute coronary syndrome. Clinical Chemistry. 2009; 131:738-43. doi: 10.1309/AJCP3CX3AUVRBHCF PMID: 19369636
61. Gilbot S, Massin F, Cravoisy A, Dupays R, Barraud D, Nace L, et al. Growth arrest-specific protein 6 plasma concentrations during septic shock. Critical Care. 2007; 11(1):R8. PMID: 17241453
62. Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, KwiatkowskiW. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature. 2002; 420:636-42. PMID: 12478285
63. Jeong YH, Sekiya M, Hirata M, Ye M, Yamagishi A, Lee SM, et al. The low-density lipoprotein receptor-related protein 10 is a negative regulator of the canonical Wnt/beta-catenin signaling pathway. Biochemical and biophysical research communications. 2010; 392(4):495-9. doi: 10.1016/j.bbrc.2010.01.049 PMID: 20093106.
64. Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P, et al. Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nature communications. 2012; 3:735. doi: 10.1038/ncomms1734 PMID: 22415826; PubMed Central PMCID: PMC3316881.